House Republicans Press FDA On Warning Letter Appeals
Executive Summary
FDA leadership needs to review the agency's enforcement dispute resolution process, leading Republicans on the House Energy and Commerce Committee assert
You may also be interested in...
House Republicans unhappy with FDA dispute procedures
A personal meeting to resolve questions about FDA's dispute resolution process is requested by Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., in an April 3 letter to FDA Commissioner Andrew von Eschenbach. The ranking members of the House Energy & Commerce Committee and its Oversight & Investigation Subcommittee, respectively, say they are "troubled" by FDA's response to previous questions about agency enforcement priorities and dispute resolution (1"The Pink Sheet," Nov. 26, 2007, p. 17). They are asking that von Eschenbach meet with them sometime before an April 22 hearing on FDA resources...
House Republicans unhappy with FDA dispute procedures
A personal meeting to resolve questions about FDA's dispute resolution process is requested by Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., in an April 3 letter to FDA Commissioner Andrew von Eschenbach. The ranking members of the House Energy & Commerce Committee and its Oversight & Investigation Subcommittee, respectively, say they are "troubled" by FDA's response to previous questions about agency enforcement priorities and dispute resolution (1"The Pink Sheet," Nov. 26, 2007, p. 17). They are asking that von Eschenbach meet with them sometime before an April 22 hearing on FDA resources...
House Republicans Challenge FDA On Warning Letter Appeals Process
Senior House Republicans are challenging FDA on the fairness of its warning letter appeals process